跳至主要内容
临床试验/NCT04222816
NCT04222816已完成4 期

Effect of Regulated Add -on Sodium Chloride Intake on Stabilization of Serum Lithium Concentration in Bipolar Disorder: A Randomized Controlled Trial

All India Institute of Medical Sciences, Bhubaneswar1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年1月16日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
发起方
入组人数
60
试验地点
1
主要终点
Difference in percentage of bipolar patients showing fluctuation in serum lithium level

研究概览

简要总结

Bipolar affective disorder or manic -depressive psychosis (MDP) is a mood disorder affecting 2.4% of the global population . Lithium is considered as the "gold standard" for the treatment of bipolar disorder but the clinical use of lithium is often restricted due to its narrow therapeutic range and adverse effects.

In a published case report, Bleiwiss H found that sodium chloride supplementation diminished the adverse effects caused by lithium The literature search also revealed that till date, there is no published clinical study evaluating the effect of dietary intake of sodium in preventing the fluctuations of serum lithium level and lithium toxicity Therefore, a randomized clinical trial has been designed to evaluate the effect of regulated add -on dietary sodium chloride on serum lithium levels in bipolar disorder.

详细描述

Bipolar affective disorder or manic -depressive psychosis (MDP) is a mood disorder affecting 2.4% of the global population. Lithium is considered as the "gold standard" for the treatment of bipolar disorder but the clinical use of lithium is often restricted due to its narrow therapeutic range and adverse effects.One of the major adverse effects of lithium is nephrogenic diabetes insipidus which is due to long -term renal dysfunction.

In the initial months of lithium therapy, psychiatrists face difficulty in titrating the dose and stabilizing serum lithium level and this fluctuation of serum lithium level may be due to a lithium-induced sodium depleted state.

In a published case report, Bleiwiss H found that sodium chloride supplementation diminished the adverse effects caused by lithium. 8 In another case report, Tomita et al demonstrated that the change in sodium chloride intake can bring about changes in serum lithium and help in stabilizing the levels of serum lithium concentration.

As all the case reports are from abroad, the effect of dietary sodium on serum lithium level among Indian population is completely unknown. The literature search also revealed that till date, there is no published clinical study evaluating the effect of dietary intake of sodium in preventing the fluctuations of serum lithium level and lithium toxicity. Therefore, a randomized clinical trial has been designed to evaluate the effect of regulated add -on dietary sodium chloride on serum lithium levels in bipolar disorder. This study may help to explore the role of add -on sodium chloride in decreasing the fluctuations in the serum lithium level and improving the clinical outcome of patients with bipolar disorders.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Patients aged 18 -60 years, of either sex with the clinical diagnosis of bipolar disorder (DSM V) who are on maintenance lithium therapy for ≥ 1month and ≤ 6 months.
  • Patients with normal serum sodium level (135 -145 mEq/L) and serum lithium in the optimum therapeutic range (<0.6 mEq/ L or >0.8 mEq/ L) .

排除标准

  • Patients with comorbidities like other psychiatric disorder s, organicity, substance abuse, personality disorder, intellectual disability and other neurotic disorders .
  • Patients with any renal, cardiovascular, neurologica l, endocrinal and hepatic dysfunction.
  • Patients suffering from diarrhoea, dehydration
  • History of any invasive neurosurgical/ non -invasive neuropsychiatric procedure.
  • Medication history of psychoactive or central nervous system depressant drugs.
  • Patients who are on NSAIDs, ACE inhibitors, antiarrhythmics, diuretics and neuromuscular blocking agents .
  • Pregnant and nursing women .
  • Patients with drug/alcohol abuse.

研究组 & 干预措施

Lithium carbonate

Active Comparator

Lithium carbonate is prescribed 800-900 mg per day for 12 weeks.

干预措施: Lithium Carbonate (Drug)

Add-on Sodium chloride

Experimental

Sodium chloride 1gm per day per will be prescribed along with Lithium carbonate 800-900 mg per day for 12 weeks.

干预措施: Lithium Carbonate (Drug)

Add-on Sodium chloride

Experimental

Sodium chloride 1gm per day per will be prescribed along with Lithium carbonate 800-900 mg per day for 12 weeks.

干预措施: Sodium chloride (Drug)

结局指标

主要结局

Difference in percentage of bipolar patients showing fluctuation in serum lithium level

时间窗: 12 weeks

Serum lithium level will be done by electrolyte analyzer. The patients showing fluctuations ( fluctuation is defined as serum lithium \<0.6 mEq/ L or \>0.8 mEq/ L in maintenance phase) in serum lithium level between the groups over 12 weeks.

次要结局

  • Serum sodium(12 weeks)
  • Serum creatinine(12 weeks)
  • ECG changes(12 weeks)
  • Serum Lithium(12 weeks)
  • Serum Potassium(12 weeks)
  • Serum aldosterone(12 weeks)

研究者

发起方
All India Institute of Medical Sciences, Bhubaneswar
申办方类型
Other
责任方
Principal Investigator
主要研究者

RITUPARNA MAITI

Additional Professor

All India Institute of Medical Sciences, Bhubaneswar

研究点 (1)

Loading locations...

相似试验

Effect of Regulated Add -on Sodium Chloride Intake... | 临床试验